Czech National Bank raised its position in Centene Co. (NYSE:CNC – Free Report) by 5.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 107,157 shares of the company’s stock after acquiring an additional 5,463 shares during the quarter. Czech National Bank’s holdings in Centene were worth $8,067,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of the stock. Davis Capital Management lifted its position in shares of Centene by 8.0% during the 3rd quarter. Davis Capital Management now owns 17,658 shares of the company’s stock worth $1,329,000 after buying an additional 1,306 shares during the last quarter. Paragon Capital Management Inc. lifted its position in shares of Centene by 8.5% during the 2nd quarter. Paragon Capital Management Inc. now owns 24,342 shares of the company’s stock worth $1,614,000 after buying an additional 1,910 shares during the last quarter. Sanctuary Advisors LLC purchased a new stake in shares of Centene during the 2nd quarter worth approximately $3,373,000. Granite Bay Wealth Management LLC purchased a new stake in Centene in the 2nd quarter valued at $206,000. Finally, NewEdge Advisors LLC raised its position in Centene by 64.0% in the 2nd quarter. NewEdge Advisors LLC now owns 32,481 shares of the company’s stock valued at $2,154,000 after purchasing an additional 12,674 shares during the last quarter. Hedge funds and other institutional investors own 93.63% of the company’s stock.
Centene Stock Performance
NYSE:CNC opened at $72.08 on Friday. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.64. Centene Co. has a fifty-two week low of $63.45 and a fifty-two week high of $81.42. The stock has a market cap of $38.47 billion, a PE ratio of 14.33, a price-to-earnings-growth ratio of 1.02 and a beta of 0.48. The firm’s fifty day simple moving average is $75.80 and its 200-day simple moving average is $73.24.
Analyst Upgrades and Downgrades
CNC has been the subject of several research reports. StockNews.com upgraded shares of Centene from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 29th. TD Cowen upped their price target on shares of Centene from $80.00 to $89.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Jefferies Financial Group downgraded shares of Centene from a “buy” rating to a “hold” rating and reduced their price target for the company from $83.00 to $69.00 in a research report on Wednesday, July 24th. Barclays dropped their price objective on shares of Centene from $98.00 to $97.00 and set an “overweight” rating on the stock in a research note on Thursday, September 5th. Finally, Oppenheimer dropped their price objective on shares of Centene from $110.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, July 29th. Seven investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $85.58.
Check Out Our Latest Report on CNC
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Stories
- Five stocks we like better than Centene
- Most Volatile Stocks, What Investors Need to Know
- 3 Key Stocks to Ride China’s Stimulus-Driven Growth
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Dividend Growth Stocks Set to Supercharge Your Portfolio
- What is Put Option Volume?
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.